Pancreatic Cancer Research

ResearcherHebrew University of JerusalemActive in the last 2 years

Ela Elyada

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5070920392. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
73
Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 9

  1. Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer. Co-author DOI 10.1038/s41588-026-02714-8↗
  2. Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8+ T cell activation and limit responsiveness to immunotherapy in mice. Co-author DOI 10.1038/s41467-024-50441-7↗
  3. RBFOX2 modulates a metastatic signature of alternative splicing in pancreatic cancer. Co-author DOI 10.1038/s41586-023-05820-3↗
  4. Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-20-3715↗
  5. Detection of incipient pancreatic cancer with novel tumor-specific antibodies in mouse models Co-author DOI 10.1101/2020.09.10.292193↗
  6. IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/2159-8290.cd-18-0710↗
  7. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Co-author DOI 10.1158/2159-8290.cd-19-0094↗
  8. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. Co-author DOI 10.1084/jem.20162024↗
  9. Organoid models of human and mouse ductal pancreatic cancer. Co-author DOI 10.1016/j.cell.2014.12.021↗

Closest collaborators

The 25 strongest of 73 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. David Arthur Tuveson · 7 shared papers, 2015–2026 · strength 0.63
  2. Giulia Biffi · 6 shared papers, 2015–2021 · strength 0.42
  3. Tobiloba E. Oni · 5 shared papers, 2015–2021 · strength 0.35
  4. Youngkyu Park · 5 shared papers, 2015–2021 · strength 0.34
  5. Talia Golan · 2 shared papers, 2023–2024 · strength 0.30
  6. Hao Yuan · 4 shared papers, 2015–2021 · strength 0.29
  7. Pasquale Laise · 2 shared papers, 2019–2026 · strength 0.28
  8. Andrea Califano · 2 shared papers, 2019–2026 · strength 0.28
  9. Alina Cornelia Iuga · 1 shared paper, 2026 · strength 0.21
  10. Álvaro Curiel‐García · 1 shared paper, 2026 · strength 0.21
  11. Sabrina Ge · 1 shared paper, 2026 · strength 0.21
  12. H. Carlo Maurer · 1 shared paper, 2026 · strength 0.21
  13. Urszula N. Wasko · 1 shared paper, 2026 · strength 0.21
  14. Faiyaz Notta · 1 shared paper, 2026 · strength 0.21
  15. Kenneth P. Olive · 1 shared paper, 2026 · strength 0.21
  16. Gulam Abbas Manji · 1 shared paper, 2026 · strength 0.21
  17. Kenneth H. Yu · 3 shared papers, 2015–2020 · strength 0.19
  18. Benjamin Assouline · 1 shared paper, 2024 · strength 0.16
  19. Ittai Ben‐Porath · 1 shared paper, 2024 · strength 0.16
  20. Ofra Benny · 1 shared paper, 2024 · strength 0.16
  21. Eliana Steinberg · 1 shared paper, 2024 · strength 0.16
  22. Ben Z. Stanger · 1 shared paper, 2024 · strength 0.16
  23. Jason Robert Pitarresi · 1 shared paper, 2024 · strength 0.16
  24. Gideon A. Zamir · 1 shared paper, 2024 · strength 0.16
  25. Dannielle D. Engle · 3 shared papers, 2015–2019 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.